Cargando…

Antibiotic Prophylaxis for Presumptive Group B Streptococcal Infection in Preterm Premature Rupture of the Membranes: Effect on Neonatal and Maternal Infectious Morbidity

Objective: The purpose of this study was to determine if the prevalence of neonatal and maternal infectious morbidity in patients with preterm premature rupture of membranes (PROM) who received ampicillin prophylaxis for presemptive group B streptococcal colonization is increased compared to those w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kramer, Wayne B., Saade, George R., Belfort, Michael, Samora-Mata, Joanne, Wen, Tony, Moise, Kenneth J.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364520/
https://www.ncbi.nlm.nih.gov/pubmed/18476117
http://dx.doi.org/10.1155/S1064744996000634
_version_ 1782153973961064448
author Kramer, Wayne B.
Saade, George R.
Belfort, Michael
Samora-Mata, Joanne
Wen, Tony
Moise, Kenneth J.
author_facet Kramer, Wayne B.
Saade, George R.
Belfort, Michael
Samora-Mata, Joanne
Wen, Tony
Moise, Kenneth J.
author_sort Kramer, Wayne B.
collection PubMed
description Objective: The purpose of this study was to determine if the prevalence of neonatal and maternal infectious morbidity in patients with preterm premature rupture of membranes (PROM) who received ampicillin prophylaxis for presemptive group B streptococcal colonization is increased compared to those who received no prophylaxis. Methods: The charts of all patients with preterm PROM who delivered between January 1988 and December 1993 were retrospectively reviewed. The routine use of ampicillin prophylaxis was initiated in January 1991. Patients with singleton gestations were included in the analysis only if chorioamnionitis was excluded on admission. Variables used in the final analysis included gestational age at the time of preterm PROM, gestational age at delivery, duration of rupture of membranes, birth weight, method of delivery, use of steroids, tocolytics, or antibiotics for group B streptococcus prophylaxis, neonatal sepsis, neonatal mortality, and postpartum endomyometritis. Data were analyzed using Student's t-test, chi-square test, Fisher's exact test, and stepwise logistic regression analysis to evaluate the effect of chemoprophylaxis for group B streptococcus on the incidence of neonatal sepsis and maternal postpartum endomyometritis. A two-tailed P < 0.05 was used to denote statistical significance. Results: The charts of 206 patients were reviewed; 146 patients received ampicillin for group B streptococcal prophylaxis and 60 patients did not. There was a significantly higher incidence of postpartum endomyometritis among the patients who received ampicillin (62% vs. 22%; P < 0.01). The association between postpartum endomyometritis and chemoprophylaxis remained significant even after controlling for other confounding variables. There was no significant difference in the incidence of neonatal sepsis (5% vs. 7%; P = 0.7) or death (5% vs. 3%; P = 0.9) between both groups. Conclusions: Group B streptococcal prophylaxis with a short course of intravenous ampicillin increases the risk of postpartum endomyometritis in patients with premature PROM.
format Text
id pubmed-2364520
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23645202008-05-12 Antibiotic Prophylaxis for Presumptive Group B Streptococcal Infection in Preterm Premature Rupture of the Membranes: Effect on Neonatal and Maternal Infectious Morbidity Kramer, Wayne B. Saade, George R. Belfort, Michael Samora-Mata, Joanne Wen, Tony Moise, Kenneth J. Infect Dis Obstet Gynecol Research Article Objective: The purpose of this study was to determine if the prevalence of neonatal and maternal infectious morbidity in patients with preterm premature rupture of membranes (PROM) who received ampicillin prophylaxis for presemptive group B streptococcal colonization is increased compared to those who received no prophylaxis. Methods: The charts of all patients with preterm PROM who delivered between January 1988 and December 1993 were retrospectively reviewed. The routine use of ampicillin prophylaxis was initiated in January 1991. Patients with singleton gestations were included in the analysis only if chorioamnionitis was excluded on admission. Variables used in the final analysis included gestational age at the time of preterm PROM, gestational age at delivery, duration of rupture of membranes, birth weight, method of delivery, use of steroids, tocolytics, or antibiotics for group B streptococcus prophylaxis, neonatal sepsis, neonatal mortality, and postpartum endomyometritis. Data were analyzed using Student's t-test, chi-square test, Fisher's exact test, and stepwise logistic regression analysis to evaluate the effect of chemoprophylaxis for group B streptococcus on the incidence of neonatal sepsis and maternal postpartum endomyometritis. A two-tailed P < 0.05 was used to denote statistical significance. Results: The charts of 206 patients were reviewed; 146 patients received ampicillin for group B streptococcal prophylaxis and 60 patients did not. There was a significantly higher incidence of postpartum endomyometritis among the patients who received ampicillin (62% vs. 22%; P < 0.01). The association between postpartum endomyometritis and chemoprophylaxis remained significant even after controlling for other confounding variables. There was no significant difference in the incidence of neonatal sepsis (5% vs. 7%; P = 0.7) or death (5% vs. 3%; P = 0.9) between both groups. Conclusions: Group B streptococcal prophylaxis with a short course of intravenous ampicillin increases the risk of postpartum endomyometritis in patients with premature PROM. Hindawi Publishing Corporation 1996 /pmc/articles/PMC2364520/ /pubmed/18476117 http://dx.doi.org/10.1155/S1064744996000634 Text en Copyright © 1996 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kramer, Wayne B.
Saade, George R.
Belfort, Michael
Samora-Mata, Joanne
Wen, Tony
Moise, Kenneth J.
Antibiotic Prophylaxis for Presumptive Group B Streptococcal Infection in Preterm Premature Rupture of the Membranes: Effect on Neonatal and Maternal Infectious Morbidity
title Antibiotic Prophylaxis for Presumptive Group B Streptococcal Infection in Preterm Premature Rupture of the Membranes: Effect on Neonatal and Maternal Infectious Morbidity
title_full Antibiotic Prophylaxis for Presumptive Group B Streptococcal Infection in Preterm Premature Rupture of the Membranes: Effect on Neonatal and Maternal Infectious Morbidity
title_fullStr Antibiotic Prophylaxis for Presumptive Group B Streptococcal Infection in Preterm Premature Rupture of the Membranes: Effect on Neonatal and Maternal Infectious Morbidity
title_full_unstemmed Antibiotic Prophylaxis for Presumptive Group B Streptococcal Infection in Preterm Premature Rupture of the Membranes: Effect on Neonatal and Maternal Infectious Morbidity
title_short Antibiotic Prophylaxis for Presumptive Group B Streptococcal Infection in Preterm Premature Rupture of the Membranes: Effect on Neonatal and Maternal Infectious Morbidity
title_sort antibiotic prophylaxis for presumptive group b streptococcal infection in preterm premature rupture of the membranes: effect on neonatal and maternal infectious morbidity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364520/
https://www.ncbi.nlm.nih.gov/pubmed/18476117
http://dx.doi.org/10.1155/S1064744996000634
work_keys_str_mv AT kramerwayneb antibioticprophylaxisforpresumptivegroupbstreptococcalinfectioninpretermprematureruptureofthemembraneseffectonneonatalandmaternalinfectiousmorbidity
AT saadegeorger antibioticprophylaxisforpresumptivegroupbstreptococcalinfectioninpretermprematureruptureofthemembraneseffectonneonatalandmaternalinfectiousmorbidity
AT belfortmichael antibioticprophylaxisforpresumptivegroupbstreptococcalinfectioninpretermprematureruptureofthemembraneseffectonneonatalandmaternalinfectiousmorbidity
AT samoramatajoanne antibioticprophylaxisforpresumptivegroupbstreptococcalinfectioninpretermprematureruptureofthemembraneseffectonneonatalandmaternalinfectiousmorbidity
AT wentony antibioticprophylaxisforpresumptivegroupbstreptococcalinfectioninpretermprematureruptureofthemembraneseffectonneonatalandmaternalinfectiousmorbidity
AT moisekennethj antibioticprophylaxisforpresumptivegroupbstreptococcalinfectioninpretermprematureruptureofthemembraneseffectonneonatalandmaternalinfectiousmorbidity